(2Z)-2-cyano-2-[5-[(2,3-dichlorophenyl)methyl]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-naphthalen-1-ylacetamide
Formula:C29H19N3O2Cl2S
Mutagenic:high
Tumorigenic:high
Reproductive Effective:high
(2Z)-2-cyano-2-[5-[(2,3-dichlorophenyl)methyl]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-naphthalen-1-ylacetamide is not a drug-like molecule.
| MolName | (2Z)-2-cyano-2-[5-[(2,3-dichlorophenyl)methyl]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-naphthalen-1-ylacetamide |
| MolecularFormula | C29H19N3O2Cl2S |
| Smiles | N#C/C(/C(Nc1cccc2ccccc12)=O)=C(\N1c2ccccc2)/SC(Cc2cccc(Cl)c2Cl)C1=O |
| InChI | InChI=1S/C29H19Cl2N3O2S/c30-23-14-6-10-19(26(23)31)16-25-28(36)34(20-11-2-1-3-12-20)29(37-25)22(17-32)27(35)33-24-15-7-9-18-8-4-5-13-21(18)24/h1-15,25H,16H2,(H,33,35)/t25-/m0/s1 |
| InChIK | WAEQHONPYKEXSP-VWLOTQADSA-N |
| TotalMolweight | 544.461 |
| Molweight | 544.461 |
| MonoisotopicMass | 543.057501 |
| CLogP | 7.1215 |
| CLogS | -8.892 |
| H Acceptors | 5 |
| H Donors | 1 |
| TotalSurfaceArea | 390.36 |
| Relative PSA | 0.1848 |
| PolarSurfaceArea | 98.5 |
| Druglikeness | 1.2571 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | polar activated DB; twice activated DB |
| Shape Index | 0.43243 |
| Fragments | 1 |
| Non HAtoms | 37 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 22 |
| Sp3Atoms | 3 |
| Symmetricatoms | 2 |
| Amides | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (2Z)-2-cyano-2-[5-[(2,3-dichlorophenyl)methyl]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-naphthalen-1-ylacetamide | 2 - (2Z)-2-cyano-2-[5-[(2,3-dichlorophenyl)methyl]-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]-N-naphthalen-1-ylacetamide
Spacefill |
Wire |
Ball & Stick |
Iso-vdw |
Opaque |
Dot Surface |
Mep |
Translucent |
Spin |
Label On |
Off